NXL vs TDG · rev $301.6K vs P/E 41, rev $8.83B
Nexalin Technology Inc. (NXL) versus Transdigm Group Incorporated (TDG) — a side-by-side from cached financials, not a winner call.
Nexalin Technology Inc. (NXL) is a medical devices company listed on NASDAQ.
Transdigm Group Incorporated (TDG) is a aerospace & defense company listed on NYSE.
Latest reported NXL revenue for 2025-12-31 was $301.6K. Net income was -$8.2M. Revenue was up 78.8% from 2024-12-31 to 2025-12-31. NXL currently screens at market cap $8.5M.
Latest reported TDG revenue for 2025-09-30 was $8.83B. Net income was $2.07B. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
NXL currently screens at market cap $8.5M. TDG currently screens at market cap $73.65B and trailing P/E 41.1.
Not investment advice. Open the NXL and TDG stock pages for the full models.
Not investment advice.